Response to Letter
- PMID: 31856105
- DOI: 10.1097/AOG.0000000000003632
Response to Letter
Comment on
-
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis.Obstet Gynecol. 2019 Sep;134(3):537-544. doi: 10.1097/AOG.0000000000003413. Obstet Gynecol. 2019. PMID: 31403606
-
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis.Obstet Gynecol. 2020 Jan;135(1):217. doi: 10.1097/AOG.0000000000003631. Obstet Gynecol. 2020. PMID: 31856104 No abstract available.
References
-
- Mallampati D, Grobman W, Rouse DJ, Werner EF. Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis. Obstet Gynecol 2019;134:537–44.
-
- Abheiden CN, van Reuler AV, Fuijkschot WW, de Vries JI, Thijs A, de Boer MA. Aspirin adherence during high-risk pregnancies, a questionnaire study. Pregnancy Hypertens 2016;6:350–5.
-
- Mone F, Mulcahy C, McParland P, Breathnach F, Downey P, McCormack D, et al. Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial. BMJ Open 2018;8:e022056.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
